Didier Carrié - Concepedia

Author

Didier Carrié

Also Known As

Carrie, D., Carrie, Daniel, Carrié D, Carrié, Daniel, Carrié, Didier, D CARRIE, D Carrie, D Carrié, D. CARRIE, D. CARRIÉ

728

Publications

26.1K

Citations

H-Index

128

Concepts

All Affiliations

Hôpital Rangueil Inserm Université Toulouse III - Paul Sabatier Université Fédérale de Toulouse Midi-Pyrénées Centre Hospitalier Universitaire de Toulouse

About

Didier Carrié is an author at Hôpital Rangueil specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	98	9.5K
2	Health Sciences	7	7	619
3	Engineering	3	3	307
4	Education	1	1	47
5	Nursing	1	1	18

Didier Carrié

213

Publications

21K

Citations

H-Index

Page 1

	Year	Citations
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Jean‐François Obadia, David Messika‐Zeitoun, Guillaume Leurent, New England Journal of Medicine	2018	1.7K
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients Martine Gilard, Hélène Eltchaninoff, Bernard Iung, New England Journal of Medicine	2012	1.2K
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting Jean‐Philippe Collet, Thomas Cuisset, Grégoire Rangé, New England Journal of Medicine	2012	871
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk Philip Urban, Ian T. Meredith, Alexandre Abizaid, New England Journal of Medicine	2015	790
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Pascal Vranckx, Marco Valgimigli, Peter Jüni, The Lancet Endovascular TechniqueCardiovascular DiseaseRandomised Superiority TrialLumen-apposing Metal StentPharmacotherapy	2018	761
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys, The Lancet Percutaneous Coronary InterventionControlled Syntax TrialEndovascular TechniqueCardiovascular DiseaseHealth Policy	2019	618
Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction Christian Spaulding, Patrick Henry, Emmanuel Teíger, New England Journal of Medicine	2006	562
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, The Lancet Percutaneous Coronary InterventionAbsorb IiEndovascular TechniqueCardiovascular DiseaseAtherosclerosis	2014	556
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi, The Lancet Percutaneous Coronary InterventionAbsorb IiEverolimus-eluting Metallic StentCardiovascular DiseaseEndovascular Technique	2016	534
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients Martine Gilard, Hélène Eltchaninoff, Bernard Iung, Survey of Anesthesiology Cardiovascular DiseaseTranscatheter Aortic-valve ImplantationPatient SafetyVascular SurgeryValve Disease	2013	453

Page 1